Highlights
NASDAQ: ARCT       Arcturus Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
10.95   +0.13 (1.20%)  10.81 - 11.365  2,136

Overview

 
Avg Volume (4 weeks):70,916
4 Weeks Range:9.70 - 12.587
4 Weeks Price Volatility (%):
43.30%
52 Weeks Range:4.255 - 15.50
52 Weeks Price Volatility (%):
59.54%
Average Price Target: 12.00
Price Target Upside/Downside: +1.05

Headlines



No recent Headlines for this stock.


Business Background

Alcobra Ltd is a biopharmaceutical company. It is focused on the development and commercialization of novel treatments for central nervous system and cognitive disorders. The company' s product candidates include Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; and Metadoxine Extended Release (MDX), a proprietary oral drug for the treatment of ADHD and other cognitive disorders, including Fragile X syndrome. Geographically all the operations are operated through the regions of Israel.

  Be the first to like this.
 


 

1617  3600  633  3114 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 GE 12.695+0.965 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 AMD 46.45-4.08 
 ECA 3.79-0.25 
 BBT 54.24+0.75 
 CHK 0.54+0.022 
Partners & Brokers